Evidence map›Paper›PMID 38739603›Full record

ArticlePloS one2024

Fusion of histone variants to Cas9 suppresses non-homologous end joining.

Tomoko Kato-Inui, Gou Takahashi, Terumi Ono, Yuichiro Miyaoka

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Tomoko Kato-InuiTokyo Metropolitan Institute of Medical Science, Regenerative Medicine Project, Tokyo, Japan.
Gou TakahashiTokyo Metropolitan Institute of Medical Science, Regenerative Medicine Project, Tokyo, Japan.ORCID 0000-0003-2277-7657
Terumi OnoTokyo Metropolitan Institute of Medical Science, Regenerative Medicine Project, Tokyo, Japan.
Yuichiro MiyaokaTokyo Metropolitan Institute of Medical Science, Regenerative Medicine Project, Tokyo, Japan.ORCID 0000-0002-8874-4738

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a versatile genome editing tool, the CRISPR-Cas9 system induces DNA double-strand breaks at targeted sites to activate mainly two DNA repair pathways: HDR which allows precise editing via recombination with a homologous template DNA, and NHEJ which connects two ends of the broken DNA, which is often accompanied by random insertions and deletions. Therefore, how to enhance HDR while suppressing NHEJ is a key to successful applications that require precise genome editing. Histones are small proteins with a lot of basic amino acids that generate electrostatic affinity to DNA. Since H2A.X is involved in DNA repair processes, we fused H2A.X to Cas9 and found that this fusion protein could improve the HDR/NHEJ ratio by suppressing NHEJ. As various post-translational modifications of H2A.X play roles in the regulation of DNA repair, we also fused H2A.X mimicry variants to replicate these post-translational modifications including phosphorylation, methylation, and acetylation. However, none of them were effective to improve the HDR/NHEJ ratio. We further fused other histone variants to Cas9 and found that H2A.1 suppressed NHEJ better than H2A.X. Thus, the fusion of histone variants to Cas9 is a promising option to enhance precise genome editing.

Indexed as

CRISPR-Associated Protein 9CRISPR-Cas SystemsDNA End-Joining RepairGene EditingHistonesAcetylationDNA Breaks, Double-StrandedHEK293 CellsHumansProtein Processing, Post-TranslationalRecombinant Fusion ProteinsCRISPR-Associated Protein 9HistonesRecombinant Fusion Proteins

Identifiers

PMID38739603
PMCPMC11090291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.